High-depth next-generation sequencing panel testing in the evaluation of arteriovenous malformations

Patricia V Hernandez1, Katherine A King2, Michael J Evenson1

  • 1Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.

Summary

This study found that a high-depth next-generation sequencing (NGS) panel for Disorders of Somatic Mosaicism (DoSM) identified pathogenic variants in 68.5% of patients with arteriovenous malformations (AVMs). This molecular diagnostic yield highlights the panel's utility in diagnosing AVMs.